KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Change in Cash (2016 - 2025)

Bausch Health Companies' Change in Cash history spans 17 years, with the latest figure at -$15.0 million for Q4 2025.

  • For Q4 2025, Change in Cash fell 103.33% year-over-year to -$15.0 million; the TTM value through Dec 2025 reached $124.0 million, down 48.12%, while the annual FY2025 figure was $124.0 million, 48.12% down from the prior year.
  • Change in Cash for Q4 2025 was -$15.0 million at Bausch Health Companies, up from -$403.0 million in the prior quarter.
  • Across five years, Change in Cash topped out at $586.0 million in Q2 2025 and bottomed at -$1.4 billion in Q3 2022.
  • The 5-year median for Change in Cash is $21.5 million (2021), against an average of -$24.5 million.
  • The largest annual shift saw Change in Cash tumbled 9771.43% in 2022 before it skyrocketed 543.94% in 2025.
  • A 5-year view of Change in Cash shows it stood at $215.0 million in 2021, then tumbled by 56.28% to $94.0 million in 2022, then soared by 93.62% to $182.0 million in 2023, then soared by 147.8% to $451.0 million in 2024, then plummeted by 103.33% to -$15.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Change in Cash are -$15.0 million (Q4 2025), -$403.0 million (Q3 2025), and $586.0 million (Q2 2025).